Double-Faced Immunological Effects of CDK4/6 Inhibitors on Cancer Treatment: Challenges and Perspectives

Double-Faced Immunological Effects of CDK4/6 Inhibitors on Cancer Treatment: Challenges and Perspectives

Cyclin-dependent kinases (CDKs) are generally involved in the progression of cell cycle and cell division in normal cells, while abnormal activations of CDKs are deemed to be a driving force for accelerating cell proliferation and tumorigenesis. Therefore, CDKs have become ideal therapeutic targets...

Full description

Saved in:
Bibliographic Details
Main Authors: Yongqin Liu, Yiying Deng, Chang Yang, Hua Naranmandura
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Bioengineering
Subjects:
CDK4/6 inhibitor
immunomodulatory effect
drug resistance
immune microenvironment
immunotherapy
Online Access:https://www.mdpi.com/2306-5354/11/11/1084
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items